Essais liés4clinical trials
VilleLong Beachlocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT07602582

Ouvrir le site du centre

Essais cliniques associés

4
MoléculeIndication / populationPhaseNCTTitreStatut
Donanemab Alzheimer Phase 3 NCT07602582 A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT). RECRUITING
Trontinemab Alzheimer Phase 3 NCT07717411 PrevenTRON — A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease RECRUITING
Trontinemab Alzheimer Phase 3 NCT07170150 TRONTIER 2 — A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease ACTIVE_NOT_RECRUITING
LY3439539 Alzheimer Phase 1 NCT07598370 A Study of LY3439539 in Participants With Alzheimer's Disease RECRUITING